CollPlant Biotechnologies has officially regained compliance with Nasdaq's listing rule requiring a minimum bid price of $1.00 per share after its stock price stayed above this threshold for ten consecutive business days. This follows a prior deficiency notice in March 2026 when the stock traded below $1.00. The compliance confirmation closes the matter and supports CollPlant's strategic growth, including its recent acquisition of LightSolver, which advances its high-performance computing and photonics technologies. The company plans to continue developing its photonic computing and proprietary rhCollagen platform to create long-term shareholder value.
CollPlant Biotechnologies' Nasdaq compliance update is presented here with Pluang's Technology sector data for context. For readers following Technology stocks, 87 of 150 priced US stocks rose while 58 fell as of Sep 22, 2026 18:02 WIB. Notable prices include Expensify Inc at USD 2.29 with 100% buy orders, Transocean Ltd at USD 5.38, and Salesforce Inc at USD 239.35 with 99% buy orders.
Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...
HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...
A director at FormFactor sold 2,100 shares, indicating a notable insider transaction. Such sales can reflect personal financial decisions or strategic portfolio adjustments by company insiders. Investors often watch these moves for potential signals ...
Smiths Group reported solid fiscal 2026 results, meeting EPS and revenue expectations with an EPS of $0.66 and revenue of $1.37 billion. The company improved operating profit, driven by strategic portfolio changes including selling non-core divisions...
Cintas Corporation is set to report its Q3 earnings with an expected EPS of $1.35 and revenue of $2.98 billion, up from $2.72 billion last year. The growth is supported by strong customer retention, increased demand for services like AED Rentals, and...
